CADENCE PHARMA (NASDAQ:CADX)
8.72
+0.02 (0.23%)
| CADENCE PHARMA (NASDAQ:CADX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $8.70 | 52 Week High | $12.68 | ||
| Open | $8.87 | 52 Week Low | $4.39 | ||
| Day High | $8.93 | P/E | N/A | ||
| Day Low | $8.65 | EPS | $-1.01 | ||
| Volume | 270,511 | ||||
| More CADX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| NDAQ | 2 | OCNF | 1 |
| ARQL | 1 | CFL | 1 |
| DYN | 1 | GNVC | 1 |
| IMAX | 1 | LEAP | 1 |
| MRT | 1 | PDC | 1 |
| RSCR | 1 | STKL | 1 |
Entities who have mentioned CADX
- Carl Icahn | View Related Stories »
- Banc of America | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- Piper Jaffray | View Related Stories »
- Deutsche Bank | View Related Stories »
- Morgan Stanley | View Related Stories »
- Merrill Lynch | View Related Stories »
- Robert W Baird | View Related Stories »
- Wedbush Morgan | View Related Stories »
- JMP Securities | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- GLG Partners | View Related Stories »
- David Faber | View Related Stories »
- Trading Radar | View Related Stories »
- Charles Gasparino | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- JPMorgan | View Related Stories »
- Jefferies & Co | View Related Stories »
- UBS | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- New Enterprise Associates | View Related Stories »
- Facebook | View Related Stories »
- Twitter | View Related Stories »
- Central Securities Corp. | View Related Stories »
View All Major News StreetInsider.com Major News for CADX
- FDA Extends Cadence Pharmaceuticals (CADX) PDUFA Date by Three Months
- Cadence Pharmaceuticals (CADX) Reports a Q3 Loss
- Cadence Pharma (CADX) Reports Q4 Loss of $0.37
View All ReportsStreetInsider.com Reports on CADX
- Oppenheimer Downgrades Cadence Pharmaceuticals (CADX) to Perform
- Cadence Pharma (CADX) Dec volatility at 63, Feb at 111 into FDA goal date
- FDA Extends Cadence Pharmaceuticals (CADX) PDUFA Date by Three Months
- Cadence Pharmaceuticals (CADX) Up Ahead of Tomorrow's PDUFA Date
- Cadence Pharma (CADX) Nov volatility elevated at 174 into PDUFA
View All Press ReleasesCompany Press Releases on CADX
- Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
- Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
- Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009
- Cadence Pharmaceuticals' CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
- Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
StreetInsider Reports on CADX by Category
View All BlogsBlogs on CADX
- Analyst upgrades, downgrades and initiations: DLTR, JCP, JWN, LEA, RIMM, S ...
- Biotech Busy with Bevy of Small Deals
- FDA Calendar: 2H09 Binary Event Trades
- FDA Calendar Updates: Johnson & Johnson, Cadence, Watson, Targacept
- Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines
View All FilingsSEC Filings on CADX
- Form 8-K CADENCE PHARMACEUTICALS For: Nov 13
- Form 4 Socks David A For: Nov 09
- Form 4 BREITMEYER JAMES B For: Nov 05
- Form 10-Q CADENCE PHARMACEUTICALS For: Sep 30
- Form 8-K CADENCE PHARMACEUTICALS For: Nov 05
Comments on CADX
No comments are currently available.
